Immix Biopharma, Inc.
IMMX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $0K | $0K | |
| Operating income | −$30.0M | −$22.7M | −32.1% |
| Net income | −$29.4M | −$21.6M | −36.2% |
Questions
- What was Immix Biopharma's revenue in FY2025?
- $0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Mar 2026.
- Was Immix Biopharma profitable in FY2025?
- No: net income was −$29.4M and operating income −$30.0M in FY2025.